306 - Robotic cystectomy and ileal conduit for neurogenic bladder

Patients with neurological disorders are at risk of having vesicosphincteric symptoms that are refractory to first-line treatments. In such cases, a surgical intervention such as Enterocystoplasty for bladder enlargement may be proposed. This type of surgery was mostly performed through open surgery...

Full description

Saved in:
Bibliographic Details
Published inContinence (Amsterdam) Vol. 15; p. 102230
Main Authors Peyronnet, B, Paris, H, Haudebert, C
Format Journal Article
LanguageEnglish
Published Elsevier B.V 2025
Elsevier
Subjects
Online AccessGet full text
ISSN2772-9737
2772-9737
DOI10.1016/j.cont.2025.102230

Cover

Abstract Patients with neurological disorders are at risk of having vesicosphincteric symptoms that are refractory to first-line treatments. In such cases, a surgical intervention such as Enterocystoplasty for bladder enlargement may be proposed. This type of surgery was mostly performed through open surgery, but it is now possible to offer it through minimally invasive surgery with the help of a robotic surgical system. We present the case of a young patient with spina bifida who presents with symptoms of bladder hyperactivity that did not improve with first-line treatments. A laparoscopic robot-assisted enterocystoplasty for bladder enlargement is proposed for the patient. The patient is positioned in a supine position. A laparoscopic transperitoneal approach is performed. The Da Vinci robot is placed on the operating table. Initially, a supratrigonal cystectomy is performed, followed by the resection of 40 cm of ileum after visualization of the mesenteric vasculature using an indocyanine green injection. The W-shaped enterocystoplasty is then created and sutured to the trigone. Finally, an artificial urinary sphincter is implanted. The procedure was fully performed using robot-assisted laparoscopic surgery. Enterocystoplasty after supratrigonal cystectomy for neurogenic bladder by robot-assisted laparoscopy is a technique that could reduce postoperative morbidity in these vulnerable patients. Funding No one Clinical Trial No Subjects Human Ethics not Req'd It's not a study Helsinki Yes Informed Consent Yes
AbstractList IntroductionPatients with neurological disorders are at risk of having vesicosphincteric symptoms that are refractory to first-line treatments. In such cases, a surgical intervention such as Enterocystoplasty for bladder enlargement may be proposed. This type of surgery was mostly performed through open surgery, but it is now possible to offer it through minimally invasive surgery with the help of a robotic surgical system. DesignWe present the case of a young patient with spina bifida who presents with symptoms of bladder hyperactivity that did not improve with first-line treatments. A laparoscopic robot-assisted enterocystoplasty for bladder enlargement is proposed for the patient. ResultsThe patient is positioned in a supine position. A laparoscopic transperitoneal approach is performed. The Da Vinci robot is placed on the operating table. Initially, a supratrigonal cystectomy is performed, followed by the resection of 40 cm of ileum after visualization of the mesenteric vasculature using an indocyanine green injection. The W-shaped enterocystoplasty is then created and sutured to the trigone. Finally, an artificial urinary sphincter is implanted. The procedure was fully performed using robot-assisted laparoscopic surgery. ConclusionEnterocystoplasty after supratrigonal cystectomy for neurogenic bladder by robot-assisted laparoscopy is a technique that could reduce postoperative morbidity in these vulnerable patients. Funding No one Clinical Trial No Subjects Human Ethics not Req'd It's not a study Helsinki Yes Informed Consent Yes
Introduction: Patients with neurological disorders are at risk of having vesicosphincteric symptoms that are refractory to first-line treatments. In such cases, a surgical intervention such as Enterocystoplasty for bladder enlargement may be proposed. This type of surgery was mostly performed through open surgery, but it is now possible to offer it through minimally invasive surgery with the help of a robotic surgical system. Design: We present the case of a young patient with spina bifida who presents with symptoms of bladder hyperactivity that did not improve with first-line treatments.A laparoscopic robot-assisted enterocystoplasty for bladder enlargement is proposed for the patient. Results: The patient is positioned in a supine position. A laparoscopic transperitoneal approach is performed. The Da Vinci robot is placed on the operating table. Initially, a supratrigonal cystectomy is performed, followed by the resection of 40 cm of ileum after visualization of the mesenteric vasculature using an indocyanine green injection. The W-shaped enterocystoplasty is then created and sutured to the trigone. Finally, an artificial urinary sphincter is implanted. The procedure was fully performed using robot-assisted laparoscopic surgery. Conclusion: Enterocystoplasty after supratrigonal cystectomy for neurogenic bladder by robot-assisted laparoscopy is a technique that could reduce postoperative morbidity in these vulnerable patients.Funding No one Clinical Trial No Subjects Human Ethics not Req'd It's not a study Helsinki Yes Informed Consent Yes
Patients with neurological disorders are at risk of having vesicosphincteric symptoms that are refractory to first-line treatments. In such cases, a surgical intervention such as Enterocystoplasty for bladder enlargement may be proposed. This type of surgery was mostly performed through open surgery, but it is now possible to offer it through minimally invasive surgery with the help of a robotic surgical system. We present the case of a young patient with spina bifida who presents with symptoms of bladder hyperactivity that did not improve with first-line treatments. A laparoscopic robot-assisted enterocystoplasty for bladder enlargement is proposed for the patient. The patient is positioned in a supine position. A laparoscopic transperitoneal approach is performed. The Da Vinci robot is placed on the operating table. Initially, a supratrigonal cystectomy is performed, followed by the resection of 40 cm of ileum after visualization of the mesenteric vasculature using an indocyanine green injection. The W-shaped enterocystoplasty is then created and sutured to the trigone. Finally, an artificial urinary sphincter is implanted. The procedure was fully performed using robot-assisted laparoscopic surgery. Enterocystoplasty after supratrigonal cystectomy for neurogenic bladder by robot-assisted laparoscopy is a technique that could reduce postoperative morbidity in these vulnerable patients. Funding No one Clinical Trial No Subjects Human Ethics not Req'd It's not a study Helsinki Yes Informed Consent Yes
ArticleNumber 102230
Author Haudebert, C
Peyronnet, B
Paris, H
Author_xml – sequence: 1
  givenname: B
  surname: Peyronnet
  fullname: Peyronnet, B
  organization: CHU Rennes
– sequence: 2
  givenname: H
  surname: Paris
  fullname: Paris, H
  organization: CHU Rennes
– sequence: 3
  givenname: C
  surname: Haudebert
  fullname: Haudebert, C
  organization: CHU Rennes
BookMark eNqFkd9qFTEQh4NUsNa-gFf7AnucSTabXRGhFKuFguCf65AzmZSs240ke4Tz9mY9IiKoVwlDfl9mvnkqzpa0sBDPEXYI2L-YdpSWdSdB6lqQUsEjcS6Nke1olDn77f5EXJYyAYAcEFWnz8WVgr5pmw9pn9ZIDR3LyrSmh2PjFt_Emd3cVLo_xLUJKTcLH3K656W-3c_Oe87PxOPg5sKXP88L8fnmzafrd-3d-7e311d3LSmU0Bo_ukGOrIl814-oMBBhRyNgUJp1T6HTQe_dAErDiM4bM2jGgcnpzgV1IW5PXJ_cZL_m-ODy0SYX7Y9CyvfW5TrDzJYHAtLBkfTQOeycRNJGjgYG3feElSVPLMqplMzhFw_Bbk7tZDendnNqT05r6NUpxHXKb5GzLRR5IfYxV2e1jfjv-Os_4jTH6tHNX_jIZUqHvFR_Fm2RFuzHbWnbzqQGGDqzNf3y74D__f4d55ynnQ
ContentType Journal Article
Copyright 2025 © 2025 The Authors. Published by Elsevier B.V. on behalf of International Continence Society
2025 The Authors. Published by Elsevier B.V. on behalf of International Continence Society
Copyright_xml – notice: 2025 © 2025 The Authors. Published by Elsevier B.V. on behalf of International Continence Society
– notice: 2025 The Authors. Published by Elsevier B.V. on behalf of International Continence Society
DBID 6I.
AAFTH
AAYXX
CITATION
DOA
DOI 10.1016/j.cont.2025.102230
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
DOAJ Open Access Full Text
DatabaseTitle CrossRef
DatabaseTitleList



Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2772-9737
EndPage 102230
ExternalDocumentID oai_doaj_org_article_e8c0c5fac2d04a14a21c5729708566c1
10_1016_j_cont_2025_102230
S2772973725008471
1_s2_0_S2772973725008471
GroupedDBID .1-
.FO
0R~
AALRI
AAXUO
AAYWO
ACVFH
ADCNI
ADVLN
AEUPX
AEXQZ
AFJKZ
AFPUW
AFRHN
AIGII
AITUG
AJUYK
AKBMS
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
EBS
FDB
GROUPED_DOAJ
M41
M~E
ROL
Z5R
6I.
AAFTH
AAYXX
CITATION
ID FETCH-LOGICAL-c3120-7d9a829e5ccd469131fcc14c901f35e56cf45f5ba8035091ad7785e18eca54af3
IEDL.DBID DOA
ISSN 2772-9737
IngestDate Mon Sep 15 19:42:05 EDT 2025
Thu Sep 18 00:24:13 EDT 2025
Sat Sep 27 17:13:57 EDT 2025
Sat Sep 27 20:32:06 EDT 2025
Sat Sep 27 06:10:41 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License http://creativecommons.org/licenses/by-nc-nd/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3120-7d9a829e5ccd469131fcc14c901f35e56cf45f5ba8035091ad7785e18eca54af3
OpenAccessLink https://doaj.org/article/e8c0c5fac2d04a14a21c5729708566c1
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_e8c0c5fac2d04a14a21c5729708566c1
crossref_primary_10_1016_j_cont_2025_102230
elsevier_sciencedirect_doi_10_1016_j_cont_2025_102230
elsevier_clinicalkeyesjournals_1_s2_0_S2772973725008471
elsevier_clinicalkey_doi_10_1016_j_cont_2025_102230
PublicationCentury 2000
PublicationDate 2025
2025-00-00
2025-01-01
PublicationDateYYYYMMDD 2025-01-01
PublicationDate_xml – year: 2025
  text: 2025
PublicationDecade 2020
PublicationTitle Continence (Amsterdam)
PublicationYear 2025
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
SSID ssj0002811345
Score 2.2823403
Snippet Patients with neurological disorders are at risk of having vesicosphincteric symptoms that are refractory to first-line treatments. In such cases, a surgical...
IntroductionPatients with neurological disorders are at risk of having vesicosphincteric symptoms that are refractory to first-line treatments. In such cases,...
Introduction: Patients with neurological disorders are at risk of having vesicosphincteric symptoms that are refractory to first-line treatments. In such...
SourceID doaj
crossref
elsevier
SourceType Open Website
Index Database
Publisher
StartPage 102230
SubjectTerms Urology
Title 306 - Robotic cystectomy and ileal conduit for neurogenic bladder
URI https://www.clinicalkey.com/#!/content/1-s2.0-S2772973725008471
https://www.clinicalkey.es/playcontent/1-s2.0-S2772973725008471
https://dx.doi.org/10.1016/j.cont.2025.102230
https://doaj.org/article/e8c0c5fac2d04a14a21c5729708566c1
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T8MwELYQA2JBPEV5yQMbiojjVzICKqqQygBU6mY5Z0eighbRMrDw27lL0ioDgoUliqLzI-ez7zv7fMfYOS55Boy0CcpKkShd5EnphUhMFi1JUUgj3Xce3pvBSN2N9biT6ot8wprwwA3jLmMOKejKQxZS5YXymQCNiNAiVjAGasMnLdKOMTWpt4yEkEq3t2Qahy7y_UaDMNMUriAjt-eOJqoD9ncUUkfJ3G6zrRYd8qumVztsLU532cawPf_eY1cIvXnCH2blDCk4UBhmWMxeP7mfBo4THAtjB8LH84IjGuV1tEoUEaQtX2iNed9no9v-080gaZMgJCAFmnY2FD7PiqgBApqyQooKQChAPV5JHbWBSulKlz6nM8JC-GBtrqPII3itfCUP2Pp0No2HjENA2wJVshWIgkKwJRgrg1SpwvdgYo9dLBni3ppYF27pBDZxxD5H7HMN-3rsmni2oqQ41fUHHD3Xjp77a_R6TC457pZXQXHxwoqef23a_lQqztv5N3fCzTOXuseMjAfKxKMpcYDF9vSqZAsxGujwR4tH__Gzx2yTqmw2cE7Y-uL9I54ipFmUZ7X04nP41f8GphrwoQ
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=306+-+Robotic+cystectomy+and+ileal+conduit+for+neurogenic+bladder&rft.jtitle=Continence+%28Amsterdam%29&rft.au=Peyronnet%2C+B&rft.au=Paris%2C+H&rft.au=Haudebert%2C+C&rft.date=2025&rft.pub=Elsevier+B.V&rft.issn=2772-9737&rft.eissn=2772-9737&rft.volume=15&rft_id=info:doi/10.1016%2Fj.cont.2025.102230&rft.externalDocID=S2772973725008471
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F27729737%2FS2772973725X00060%2Fcov150h.gif